Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization
- PMID: 12506101
- DOI: 10.1167/iovs.02-0276
Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization
Abstract
Purpose: Ischemia-induced neovascularization can cause catastrophic loss of vision in retinal disorders such as diabetic retinopathy. Recent studies have shown that the angiopoietin-Tie2 system is a major regulator of vascular integrity and is involved in pathologic angiogenesis. In the study described herein, the role of these molecules in ischemic retinal disorders was investigated.
Methods: Human epiretinal membranes were examined by immunohistochemistry, In situ hybridization, and reverse transcription-polymerase chain reaction (RT-PCR) analysis. Effects of angiopoietins on tube formation were studied in vitro in bovine retinal capillary endothelial cells (BRECs) and in a murine model of ischemia-induced retinal neovascularization.
Results: In human epiretinal membranes surgically obtained from eyes with ischemic retinal disorders, substantial upregulation of angiopoietin 2 (Ang2) and the receptor Tie2 was recorded than in those from eyes with nonischemic diseases, whereas expression of Ang1 was constant in all membranes. Both Ang1 and Ang2 promoted tube-forming activity and enhanced the effects of vascular endothelial growth factor (VEGF) in cultured BRECs. Soluble Tie2 fusion protein (sTie2-Fc), which precluded modulation of VEGF-dependent tube formation by the angiopoietins, suppressed both VEGF and hypoxia-conditioned, medium-induced tube-forming activity in BRECs. Intravitreal injection of sTie2-Fc, soluble Flt-1 fusion protein (sFlt-1-Fc), and both chimeric proteins suppressed retinal angiogenesis in a murine model of retinal ischemia in the order of sTie2-Fc < sFlt-1-Fc < sTie2-Fc+sFlt-1-Fc.
Conclusions: These results reinforce the substantial role of the angiopoietins/Tie2 system in ischemia-induced angiogenesis as well as the VEGF system and suggest that combined inhibition of Tie2 and VEGF signaling may be more effective in halting or preventing pathologic angiogenesis in ischemic retinal disorders.
Similar articles
-
Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.Circ Res. 1998 Aug 10;83(3):233-40. doi: 10.1161/01.res.83.3.233. Circ Res. 1998. PMID: 9710115
-
Colocalization of Tie2, angiopoietin 2 and vascular endothelial growth factor in fibrovascular membrane from patients with retinopathy of prematurity.Ophthalmic Res. 2003 Jul-Aug;35(4):217-23. doi: 10.1159/000071173. Ophthalmic Res. 2003. PMID: 12815197
-
Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells.Diabetes. 2001 Apr;50(4):867-75. doi: 10.2337/diabetes.50.4.867. Diabetes. 2001. PMID: 11289054
-
Angiopoietins in angiogenesis and beyond.Expert Opin Investig Drugs. 2003 Jun;12(6):933-41. doi: 10.1517/13543784.12.6.933. Expert Opin Investig Drugs. 2003. PMID: 12783598 Review.
-
Biomedical significance of endothelial cell specific growth factor, angiopoietin.Exp Mol Med. 2002 Mar 31;34(1):1-11. doi: 10.1038/emm.2002.1. Exp Mol Med. 2002. PMID: 11989972 Review.
Cited by
-
The use of CrossMAb technology for the generation of bi- and multispecific antibodies.MAbs. 2016 Aug-Sep;8(6):1010-20. doi: 10.1080/19420862.2016.1197457. Epub 2016 Jun 10. MAbs. 2016. PMID: 27285945 Free PMC article. Review.
-
EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown.Am J Pathol. 2006 Jan;168(1):331-9. doi: 10.2353/ajpath.2006.050435. Am J Pathol. 2006. PMID: 16400034 Free PMC article.
-
Vascular endothelial growth factor in eye disease.Prog Retin Eye Res. 2008 Jul;27(4):331-71. doi: 10.1016/j.preteyeres.2008.05.001. Epub 2008 May 28. Prog Retin Eye Res. 2008. PMID: 18653375 Free PMC article. Review.
-
Epiretinal Membrane Is Associated with Diabetic Retinopathy Severity and Cumulative Anti-VEGF Injections.Ophthalmol Sci. 2025 Feb 7;5(3):100733. doi: 10.1016/j.xops.2025.100733. eCollection 2025 May-Jun. Ophthalmol Sci. 2025. PMID: 40161463 Free PMC article.
-
Systemic Inflammation-Associated Proteins and Retinopathy of Prematurity in Infants Born Before the 28th Week of Gestation.Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6419-6428. doi: 10.1167/iovs.17-21931. Invest Ophthalmol Vis Sci. 2017. PMID: 29260199 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous